Integrated transcriptomic and single-cell analysis reveals cell cycle dysregulation and cellular heterogeneity in lung cancer.
[BACKGROUND] Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with complex molecular mechanisms underlying its pathogenesis.
- p-value p < 0.001
APA
Zhang Y, Che W, et al. (2025). Integrated transcriptomic and single-cell analysis reveals cell cycle dysregulation and cellular heterogeneity in lung cancer.. Discover oncology, 17(1), 191. https://doi.org/10.1007/s12672-025-04303-3
MLA
Zhang Y, et al.. "Integrated transcriptomic and single-cell analysis reveals cell cycle dysregulation and cellular heterogeneity in lung cancer.." Discover oncology, vol. 17, no. 1, 2025, pp. 191.
PMID
41467951
Abstract
[BACKGROUND] Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with complex molecular mechanisms underlying its pathogenesis. Understanding the transcriptional landscape and cellular heterogeneity within the tumor microenvironment is crucial for identifying potential therapeutic targets and prognostic biomarkers.
[METHODS] We performed comprehensive bulk RNA sequencing on lung cancer tissues and adjacent normal samples to identify differentially expressed genes (DEGs). Weighted gene co-expression network analysis (WGCNA) was conducted to identify functionally related gene modules associated with clinical phenotypes. Functional enrichment and pathway analyses were performed to elucidate biological significance. Single-cell RNA sequencing (scRNA-seq) was utilized to characterize cellular heterogeneity and reconstruct pseudotemporal trajectories. RT-qPCR validation was performed on A549 and H1299 lung cancer cell lines to confirm key findings.
[RESULTS] Bulk RNA-seq analysis identified extensive transcriptional reprogramming in lung cancer with symmetrical distribution of upregulated and downregulated genes. WGCNA revealed multiple co-expression modules significantly correlated with clinical traits, with turquoise and blue modules showing particularly strong associations. Functional enrichment analysis highlighted dysregulation in cell proliferation, immune response, metabolic reprogramming, and developmental signaling pathways including Wnt, Hedgehog, and estrogen signaling. Single-cell analysis identified distinct cellular populations including epithelial cells, immune cells (B cells, NK cells, dendritic cells), fibroblasts, and proliferating cells. Pseudotemporal trajectory analysis revealed dynamic cellular state transitions and identified five key cell cycle regulators (AURKA, FANCD2, HELLS, RRM2, STMN1) with stage-specific expression patterns. RT-qPCR validation confirmed significant upregulation of all five genes in both A549 (4.2 to 6.3-fold increase) and H1299 cells (3.9 to 5.9-fold increase) compared to normal bronchial epithelial cells (all p < 0.001).
[CONCLUSIONS] This integrated multi-omics approach reveals the complex transcriptional landscape and cellular heterogeneity in lung cancer.
[METHODS] We performed comprehensive bulk RNA sequencing on lung cancer tissues and adjacent normal samples to identify differentially expressed genes (DEGs). Weighted gene co-expression network analysis (WGCNA) was conducted to identify functionally related gene modules associated with clinical phenotypes. Functional enrichment and pathway analyses were performed to elucidate biological significance. Single-cell RNA sequencing (scRNA-seq) was utilized to characterize cellular heterogeneity and reconstruct pseudotemporal trajectories. RT-qPCR validation was performed on A549 and H1299 lung cancer cell lines to confirm key findings.
[RESULTS] Bulk RNA-seq analysis identified extensive transcriptional reprogramming in lung cancer with symmetrical distribution of upregulated and downregulated genes. WGCNA revealed multiple co-expression modules significantly correlated with clinical traits, with turquoise and blue modules showing particularly strong associations. Functional enrichment analysis highlighted dysregulation in cell proliferation, immune response, metabolic reprogramming, and developmental signaling pathways including Wnt, Hedgehog, and estrogen signaling. Single-cell analysis identified distinct cellular populations including epithelial cells, immune cells (B cells, NK cells, dendritic cells), fibroblasts, and proliferating cells. Pseudotemporal trajectory analysis revealed dynamic cellular state transitions and identified five key cell cycle regulators (AURKA, FANCD2, HELLS, RRM2, STMN1) with stage-specific expression patterns. RT-qPCR validation confirmed significant upregulation of all five genes in both A549 (4.2 to 6.3-fold increase) and H1299 cells (3.9 to 5.9-fold increase) compared to normal bronchial epithelial cells (all p < 0.001).
[CONCLUSIONS] This integrated multi-omics approach reveals the complex transcriptional landscape and cellular heterogeneity in lung cancer.
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.